RemoteDesk offers 10,000 FREE licenses through summer 2020 for businesses affected by Coronavirus

NEW YORK, March 12, 2020 /PRNewswire/ — RemoteDesk by Verificient announces that in response to the recent coronavirus outbreak, RemoteDesk will be offering 10,000 (ten thousand) free licenses through the summer of 2020 to qualified businesses.

The coronavirus has taken many organizations, businesses, educational institutions, and governments by surprise and these groups are recommending that people work from home to help reduce the spread of the virus. However, the shift from working from the office to working from home presents many challenges: maintaining high productivity, preserving data security, and compliance.

Rahul Siddharth, COO, Verificient Technologies, Inc, “Remote workforce management needs to be the foundation of every organization’s emergency preparedness plan or disaster recovery plan. RemoteDesk can secure teleworkers’ home office workstations and ensure continued productivity during this sudden short term coronavirus pandemic. RemoteDesk can provide full transparency, mitigate the compliance and security risks of remote agents and help solve organizations’ critical needs in adopting a long term remote workforce.”

About RemoteDesk 
RemoteDesk is the world’s most advanced AI-based remote workforce management solution for work-at-home compliance and security. RemoteDesk’s elegant and simple AI technology securely monitors teleworkers while providing clear transparency, accountability, work-at-home policy compliance, and risk management for outsourcing initiatives. RemoteDesk is powered by Verificient Technologies, Inc., which specializes in continuous identity verification through the use of its patented AI.

View original content to download multimedia:http://www.prnewswire.com/news-releases/remotedesk-offers-10-000-free-licenses-through-summer-2020-for-businesses-affected-by-coronavirus-301022150.html

SOURCE RemoteDesk

Staff

Recent Posts

RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health…

37 minutes ago

AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- ChemLex, a next-generation AI-for-science company, today announced the establishment…

37 minutes ago

Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science

The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have…

16 hours ago

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology…

16 hours ago

Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting

Longer-term analyses reinforce duvelisib’s activity across treatment-experienced PTCL populations, including patients with ≥3 prior lines…

16 hours ago